Fiona resized

Ningfeng Fiona Li, MD, PhD, MSc
Chief Executive Office &
Chief Medical Officer

Specialist in Clinical Oncology, with extensive research experience in tumour biology and carcinogenesis with publications in high impact journals.

Founder of London Nanjing Life Science (China) Ltd and Suzhou NG Biomedicine Ltd and developed several biotech reagent products, disinfectant products and small molecule pharmaceutical products through prototyping, clinical trials and recently marketing.

gary resized

Gary Bower, BSc
Chief Operating Officer

Specialist in managing Clinical Trials, with over 25 years’ experience managing studies across all phases, primarily in oncology.
Founder of GTE Consultancy Ltd, supporting small biotechnology companies with clinical & pre-clinical development since 2006.

hillaryimage

Hilary Birrell, BSc
Head of Clinical Operations

Biochemist and Clinical Trial Specialist with over 30 years’ experience in multiple indications across Phases I-IV of Drug Development. Early career in AstraZeneca followed by 20 years of consultancy experience. Owner/Director of Carnegie Clinical Research Ltd, Clinical Trial Management CRO, since 2010.

joseph resized

Joseph Irwin, BSc, MSc, MRSB, CBiol, FTOPRA, FRSM, FRSS FZS
Chief Regulatory Adviser

Biochemist/ Pharmacologist by training with experience in Clinical Trials, animal models, cell biology and molecular biology techniques. Joseph has 30 years as a regulatory professional in all therapeutic areas, in the EU, US and international markets; formal J&J Director of Regulatory Affairs EU, founder of LRCS Ltd.

Dawn Resized

Dawn A Adkin, PhD BPharm (Hons)
CMC Adviser

Independent CMC Consultant with over 25 years of experience in the pharmaceutical industry particularly in the formulation and manufacture of small molecules from early to late-stage development.
Founder of DA Squared Pharma Consulting. Former roles include Product Development Associate Director at AstraZeneca and Director at Molecular Profiles.

AustinSmith

Austin Smith, 
Deputy Chief Medical Officer

Trained and qualified in Medical Oncology and Pharmaceutical Medicine, Austin has a solid background in all aspects of Oncology and Malignant Hematology, along with Regulatory Science experience across Europe, the US and Asia-Pacific regions, acting in senior and executive positions in biopharma companies. Austin is also a member of the Expert Group for Oncology, representing the Faculty of Pharmaceutical Medicine in the UK

Key
Management

We are a pharmaceutical development company
with experienced executives and a shared vision
to improve the standard of cancer care.

Fiona resized

Ningfeng Fiona Li, MD, PhD, MSc
Chief Executive Office &
Chief Medical Officer

Specialist in Clinical Oncology, with extensive research experience in tumour biology and carcinogenesis with publications in high impact journals.

Founder of London Nanjing Life Science (China) Ltd and Suzhou NG Biomedicine Ltd and developed several biotech reagent products, disinfectant products and small molecule pharmaceutical products through prototyping, clinical trials and recently marketing.

gary resized

Gary Bower, BSc
Chief Operating Officer

Specialist in managing Clinical Trials, with over 25 years’ experience managing studies across all phases, primarily in oncology.
Founder of GTE Consultancy Ltd, supporting small biotechnology companies with clinical & pre-clinical development since 2006.

hillaryimage

Hilary Birrell, BSc
Head of Clinical Operations

Biochemist and Clinical Trial Specialist with over 30 years’ experience in multiple indications across Phases I-IV of Drug Development. Early career in AstraZeneca followed by 20 years of consultancy experience. Owner/Director of Carnegie Clinical Research Ltd, Clinical Trial Management CRO, since 2010.

joseph resized

Joseph Irwin, BSc, MSc, MRSB, CBiol, FTOPRA, FRSM, FRSS FZS
Chief Regulatory Adviser

Biochemist/ Pharmacologist by training with experience in Clinical Trials, animal models, cell biology and molecular biology techniques. Joseph has 30 years as a regulatory professional in all therapeutic areas, in the EU, US and international markets; formal J&J Director of Regulatory Affairs EU, founder of LRCS Ltd.

Dawn Resized

Dawn A Adkin, PhD BPharm (Hons)
CMC Adviser

Independent CMC Consultant with over 25 years of experience in the pharmaceutical industry particularly in the formulation and manufacture of small molecules from early to late-stage development.
Founder of DA Squared Pharma Consulting. Former roles include Product Development Associate Director at AstraZeneca and Director at Molecular Profiles.